OIRA Conclusion of EO 12866 Regulatory Review


RIN: 0910-AG88         View EO 12866 Meetings Received Date: 06/18/2013 
Title: Revision of Postmarketing Reporting Requirements Discontinuance or Interruption in Supply of Certain Products (Drug Shortages)  
Agency/Subagency: HHS / FDA   Stage: Proposed Rule 
Concluded Action: Consistent with Change  Concluded Date: 10/01/2013 
Legal Deadline: Statutory  Economically Significant: Yes 
Publication Date: 11/04/2013  Unfunded Mandates: No 
Major: Yes  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: Undetermined  Small Entities Affected:  
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected